Your browser doesn't support javascript.
loading
COL1A1::PDGFB fusion uterine sarcoma with a TERT promoter mutation.
Lu, Yang; Chen, Xinyi; Zeng, Wenjing; Hua, Ping; Shen, Yangmei; Qiu, Yan; He, Xin; Zhang, Hongying.
Afiliación
  • Lu Y; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Chen X; Department of Pathology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, China.
  • Zeng W; Department of Pathology, Longchang People's Hospital, Sichuan, China.
  • Hua P; Department of Pathology, Chengdu Women's and Children's Center Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Shen Y; Department of pathology, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Qiu Y; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • He X; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang H; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Genes Chromosomes Cancer ; 63(1): e23210, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37870859
ABSTRACT
COL1A1PDGFB fusion uterine sarcoma is a rare uterine mesenchymal tumor with some clinicopathological features that overlap with those of soft tissue dermatofibrosarcoma protuberans. However, the varied clinicopathologic and genetic characteristics have not been fully revealed, which may be a potential pitfall for diagnosis. Here, we present a case of COL1A1PDGFB fusion-positive uterine sarcoma in a 49-years-old female. Histologically, the tumor from the initial marginal excision predominantly exhibited high-grade fibrosarcomatous and myxofibrosarcoma-like appearances, while a low-grade focal area displaying storiform growth was identified in the residual tumor after subsequently extended resection. Immunohistochemically, the high-grade components mainly exhibited focal positivity for CD34 and mutated-type p53 immunoreactivity, whereas the low-grade component showed diffuse positivity for CD34 and wild-type p53 staining. The COL1A1PDGFB fusion was confirmed by fluorescence in situ hybridization and next-generation sequencing. In addition, the TERT-124 C > T mutation was further identified in this lesion's fibrosarcomatous and classic storiform components. To the best of our knowledge, this is the first described case of COL1A1PDGFB fusion uterine sarcoma with a TERT promoter mutation, which might be a novel genetic finding associated with tumorigenesis of this rare tumor.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pélvicas / Neoplasias Cutáneas / Neoplasias de los Tejidos Blandos / Neoplasias Uterinas / Dermatofibrosarcoma / Telomerasa / Fibrosarcoma Límite: Female / Humans / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pélvicas / Neoplasias Cutáneas / Neoplasias de los Tejidos Blandos / Neoplasias Uterinas / Dermatofibrosarcoma / Telomerasa / Fibrosarcoma Límite: Female / Humans / Middle aged Idioma: En Revista: Genes Chromosomes Cancer Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China
...